InflaRx NV (IFRX)
1.37
-0.02
(-1.44%)
USD |
NASDAQ |
Apr 30, 16:00
1.39
+0.02
(+1.46%)
After-Hours: 20:00
InflaRx Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
Date | Value |
---|---|
September 30, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2023
--
Maximum
Sep 2023
--
Average
--
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Affimed NV | 0.2102 |
MorphoSys AG | 12.71 |
BioNTech SE | 0.0108 |
Immatics NV | 0.00 |
CureVac NV | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 132.88M |
Total Liabilities (Quarterly) | 19.48M |
Shareholders Equity (Quarterly) | 113.39M |
Current Ratio | 6.499 |